Larimar Therapeutics, Inc. ( LRMR) - Stock Earnings
LRMR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -47.7 million USD | — USD |
| 2025Q4 | -62.5 million USD | — USD |
| 2026Q1 | -29.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
LRMR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -36.9 million USD | — USD |
| 2024 | -80.6 million USD | — USD |
| 2025 | -165.7 million USD | — USD |
| 2026 Est. | — | — |
LRMR
Price: $3.40
52 week price:
Earnings Per Share: -2.12 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 194
Market Capitalization: 271.3 million